Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Arkansas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Arkansas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Arkansas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Tamer Alsebai (NPI 1528091071)

Field	Value
Entity Type	Individual
Organization	Tamer Alsebai
Address	10001 Lile Dr
City	Little Rock
State	AR
ZIP	72205
Taxonomy	Rheumatology Physician
NPI Enumerated	July 8, 2006

Payer Source	Total Paid
Medicare	$2.2M
Medicaid	$0

Key Findings

This provider’s reimbursement profile is effectively single‑payer Medicare: Total Medicare revenue is $2.2M and Total Medicaid revenue is none (no Medicaid billing on file). The NPI was enumerated 2006-07-08 (~20 years ago), indicating long tenure in the Medicare program which supports a sustained pattern of Medicare-dependent billing activity.

Revenue is highly concentrated in a small set of biologic/injectable drug codes: the precomputed top 3 Medicare codes by revenue account for 68.9% of this provider's total Medicare revenue. Those top three are J0129 ($827.1K, 37.3%), J3262 ($382.5K, 17.3%), and J1602 ($318.5K, 14.4%), indicating that a large share of Medicare dollars flow from a few high-cost infused or injected agents.

The code mix points to an infusion‑centric rheumatology practice: high-revenue biologic drug codes J0129 (abatacept), J3262 (tocilizumab), J1602 (golimumab) and J1745 (infliximab) appear among the top items, and infusion/chemotherapy administration codes 96413, 96401 and add-on 96415 are also present. Together these codes suggest on‑site IV/subcutaneous administration of biologic and antineoplastic agents as a principal service line rather than a pure office‑visit practice.

On national competitive standing for key drugs, the provider ranks at or above typical volume for these biologics: J0129 ranks #83 of 1221 providers nationally (93th percentile; notably above typical national volume for this code), J3262 ranks #106 of 618 providers nationally (83th percentile; typical, unremarkable volume for this code), and J1602 ranks #140 of 1041 providers nationally (87th percentile; typical, unremarkable volume for this code). These ranks indicate the provider is a high‑volume national participant for abatacept and a solid regional/national billing presence for other biologics.

Several utilization metrics are statistical outliers relative to national peers: 99214 is labeled an "extreme outlier, far above typical national volume" (1.4K claims, $115K revenue; ranks #4615 of 479517 providers nationally, 99th percentile) and 96413 is also an "extreme outlier, far above typical national volume" (959 claims, $85.4K revenue; ranks #94 of 7514 providers nationally, 99th percentile). High volumes of both moderate‑complexity E/M visits and chemotherapy/infusion administrations are consistent with a busy chronic‑care infusion practice.

Ancillary diagnostics and phlebotomy support are present but represent small shares of revenue: notable lab and specimen codes include 82306 (426 claims, $12.4K, 0.6%), 86160 (811 claims, $9.7K, 0.4%), 85025 (1.3K claims, $10.7K, 0.5%) and 36415 (1.5K claims, $11.7K, 0.5%). These test and draw volumes support on‑site monitoring for autoimmune disease management but do not drive material Medicare revenue compared with biologic drugs.

Operationally, the combination of high counts of infusion administration claims (96413: 959 claims; 96415: 299 claims) and concentrated biologic drug revenue (J0129, J3262, J1602) implies recurring, resource‑intensive outpatient infusion throughput—staffing, infusion chairs, and drug acquisition/management are likely central to the practice’s cost structure. Payers and network planners should treat this provider as an infusion‑enabled rheumatology site when assessing network adequacy and rate negotiations.

For payer monitoring and contracting, the concentration of Medicare revenue in a few high‑cost biologic codes (top 3 = 68.9% of Medicare revenue) creates both leverage and risk: utilization management, site‑of‑care policies, and drug reimbursement terms for J0129, J3262 and J1602 will materially affect the provider’s revenue profile. Given no Medicaid volume on file, any change in Medicare coverage or site‑of‑care rules would have outsized impact on this provider’s overall reimbursement stream.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

69 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	24,330	$30	$827.1K
J3262	Injection, tocilizumab, 1 mg	76,500	$10	$382.5K
J1602	Injection, golimumab, 1 mg, for intravenous use	31,850	$10	$318.5K
J0897	Injection, denosumab, 1 mg	10,860	$20	$195.5K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	5,650	$30	$146.9K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,390	$80	$115K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	960	$90	$85.4K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	160	$120	$19.9K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	290	$50	$13.9K
82306	The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced…	430	$30	$12.4K

Showing 1–10 of 69

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 69 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Arkansas Distribution

Tamer Alsebai — 9 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Arkansas

Full comparison — all codes billed, vs. state median

69 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	4	20	8,960	$30	$532.4K
J3262	1	10	28,550	$1	$208.6K
J1602	3	10	15,300	$10	$185.4K
J1745	3	10	3,150	$30	$102.3K
J0897	21	160	2,580	$20	$89.7K
96413	8	80	380	$90	$36.6K
99214	73	4,300	130	$70	$18.8K
99213	2,700	4,180	100	$50	$9.6K
96401	9	60	120	$50	$8.6K
99215	110	870	30	$110	$8.5K

Showing 1–10 of 69

Related Providers

Other providers that share a Tax Identification Number (TIN) with Tamer Alsebai, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Jefferson Hospital Association Inc	AR	General Acute Care Hospital	$0	$18.4M
St Vincent Infirmary Medical Center	AR	General Acute Care Hospital	$0	$8.3M
St. Vincent Medical Group	AR	Family Medicine Physician	$0	$6.4M
Richard Houk	AR	Rheumatology Physician	$4.9M	$0
James Abraham	AR	Rheumatology Physician	$2.5M	$0
Jefferson Hospital Association, Inc	AR	Pulmonary Disease Physician	$0	$1.5M
Linda Armstrong	GA	Diagnostic Radiology Physician	$643.9K	$175.1K
Cummins Lue	AR	Rheumatology Physician	$717.3K	$0
Allen Redding	AR	Endocrinology, Diabetes & Metabolism Physician	$708.8K	$0
Brad Baltz	AR	Hematology & Oncology Physician	$633.6K	$0

Nearby Providers

Other providers in the same ZIP code as Tamer Alsebai, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
University Of Arkansas For Medical Sciences	AR	General Acute Care Hospital	$0	$87.2M
University Of Arkansas For Medical Sciences	AR	Internal Medicine Physician	$0	$28.6M
University Of Arkansas For Medical Sciences	AR	Pediatrics Physician	$0	$27.6M
Arkansas Department Of Health Immunizations	AR	Public Health or Welfare Agency	$0	$19.3M
Baptist Health	AR	General Acute Care Hospital	$0	$16.4M
Arkansas Department Of Health Family Planning Clinic	AR	Public Health or Welfare Agency	$0	$15.6M
Pediatrix Medical Group Of Arkansas PA	AR	Neonatal-Perinatal Medicine Physician	$0	$14.6M
Chenal Family Therapy, Plc	AR	Mental Health Counselor	$0	$12.2M
Francis A. Allen School For Exceptional Children, Inc.	AR	Developmentally Disabled Services Day Training Agency	$0	$11.9M
Central Arkansas Radiation Therapy Institute Inc	AR	Hematology & Oncology Physician	$0	$11M

Tamer Alsebai — Billing Profile & Reimbursement Data

Sign up for Tamer Alsebai — Billing Profile & Reimbursement Data policy alerts

Tamer Alsebai — Billing Profile & Reimbursement Data

Sign up for Tamer Alsebai — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References